{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:44:09Z","timestamp":1790772249954,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007659","name":"Bayer Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017547","name":"Spark Therapeutics Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence nationale de la recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jtha.2023.06.038","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T06:14:34Z","timestamp":1689660874000},"page":"2776-2783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumab"],"prefix":"10.1016","volume":"21","author":[{"given":"Melissa","family":"Bou-Jaoudeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Mimoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Delignat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Peyron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladislas","family":"Capdevila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Daventure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Deligne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan D.","family":"Dimitrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier D.","family":"Christophe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile V.","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Lenting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Proulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Lacroix-Desmazes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.06.038_bib1","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1056\/NEJMoa1511769","article-title":"Factor VIII\u2013mimetic function of humanized bispecific antibody in hemophilia A","volume":"374","author":"Shima","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.06.038_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/hae.13618","article-title":"The effect of emicizumab prophylaxis on health-related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 study","volume":"25","author":"Oldenburg","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2023.06.038_bib3","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa1803550","article-title":"Emicizumab prophylaxis in patients who have hemophilia A without inhibitors","volume":"379","author":"Mahlangu","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.06.038_bib4","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1703068","article-title":"Emicizumab prophylaxis in hemophilia A with inhibitors","volume":"377","author":"Oldenburg","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.06.038_bib6","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood-2006-04-017988","article-title":"A\u00a0randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study","volume":"109","author":"Astermark","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.06.038_bib7","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/emboj\/21.7.1607","article-title":"IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G","volume":"21","author":"von Pawel-Rammingen","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.jtha.2023.06.038_bib8","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3324\/haematol.2022.281895","article-title":"The IgG-degrading enzyme, Imlifidase, restores the therapeutic activity of FVIII in inhibitor-positive hemophilia A mice","volume":"108","author":"Bou-Jaoudeh","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2023.06.038_bib9","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.febslet.2013.04.039","article-title":"Rapid IgG heavy chain cleavage by the streptococcal IgG endopeptidase IdeS is mediated by IdeS monomers and is not due to enzyme dimerization","volume":"587","author":"Vindebro","year":"2013","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jtha.2023.06.038_bib10","doi-asserted-by":"crossref","first-page":"17864","DOI":"10.1073\/pnas.0904174106","article-title":"Tumor-associated and microbial proteases compromise host IgG effector functions by a single cleavage proximal to the hinge","volume":"106","author":"Brezski","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2023.06.038_bib11","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood.2019000437","article-title":"Cleavage of anti-PF4\/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia","volume":"133","author":"Kizlik-Masson","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.06.038_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2021.122836","article-title":"Bispecific antibody characterization by a combination of intact and site-specific\/chain-specific LC\/MS techniques","volume":"236","author":"Duivelshof","year":"2022","journal-title":"Talanta"},{"key":"10.1016\/j.jtha.2023.06.038_bib13","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1080\/19420862.2019.1664365","article-title":"Insights into the IgG heavy chain engineering patent landscape as applied to IgG4 antibody development","volume":"11","author":"Dumet","year":"2019","journal-title":"MAbs"},{"key":"10.1016\/j.jtha.2023.06.038_bib14","doi-asserted-by":"crossref","first-page":"7801","DOI":"10.1038\/s41467-022-35340-z","article-title":"Extensive substrate recognition by the streptococcal antibody-degrading enzymes IdeS and EndoS","volume":"13","author":"Sudol","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2023.06.038_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/intimm\/dxg036","article-title":"Evidence of allosteric conformational changes in the antibody constant region upon antigen binding","volume":"15","author":"Oda","year":"2003","journal-title":"Int Immunol"},{"key":"10.1016\/j.jtha.2023.06.038_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molimm.2004.07.004","article-title":"Conformational changes in the antibody constant domains upon hapten-binding","volume":"42","author":"Sagawa","year":"2005","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jtha.2023.06.038_bib17","doi-asserted-by":"crossref","first-page":"13917","DOI":"10.1074\/jbc.M700661200","article-title":"The immunoglobulin heavy chain constant region affects kinetic and thermodynamic parameters of antibody variable region interactions with antigen","volume":"282","author":"Torres","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.06.038_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.it.2007.11.004","article-title":"The immunoglobulin constant region contributes to affinity and specificity","volume":"29","author":"Torres","year":"2008","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jtha.2023.06.038_bib19","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.4049\/jimmunol.1201493","article-title":"A\u00a0systematic comparison of free and bound antibodies reveals binding-related conformational changes","volume":"189","author":"Sela-Culang","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jtha.2023.06.038_bib20","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1097-2765(01)00230-1","article-title":"Crystal structure at 2.8 A of an FcRn\/heterodimeric Fc complex: mechanism of pH-dependent binding","volume":"7","author":"Martin","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.jtha.2023.06.038_bib21","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1080\/19420862.2019.1633883","article-title":"Antibody Fc engineering for enhanced neonatal Fc receptor binding and prolonged circulation half-life","volume":"11","author":"Mackness","year":"2019","journal-title":"MAbs"},{"key":"10.1016\/j.jtha.2023.06.038_bib22","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.4049\/jimmunol.2000732","article-title":"V\u00a0region of IgG controls the molecular properties of the binding site for neonatal Fc receptor","volume":"205","author":"Rossini","year":"2020","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jtha.2023.06.038_bib23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fimmu.2020.00168","article-title":"The proteolytic cleavage of therapeutic monoclonal antibody hinge region: more than a matter of subclass","volume":"11","author":"Deveuve","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2023.06.038_bib24","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1182\/blood.2019004334","article-title":"A\u00a0hemophilia A mouse model for the in\u00a0vivo assessment of emicizumab function","volume":"136","author":"Ferri\u00e8re","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.06.038_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17358-2","article-title":"Pharmacokinetics, biodistribution and brain retention of a bispecific antibody-based PET radioligand for imaging of amyloid-\u03b2","volume":"7","author":"Sehlin","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2023.06.038_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12185-018-2545-9","article-title":"Emicizumab, a humanized bispecific antibody to coagulation factors IXa and X with a factor VIIIa-cofactor activity","volume":"111","author":"Kitazawa","year":"2020","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtha.2023.06.038_bib27","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1055\/s-0037-1613331","article-title":"Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor","volume":"88","author":"Hansen","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.06.038_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132011","article-title":"Complete removal of extracellular IgG antibodies in a randomized dose-escalation phase I study with the bacterial enzyme IdeS \u2013 a novel therapeutic opportunity","volume":"10","author":"Winstedt","year":"2015","journal-title":"PLoS One"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623005627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623005627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T07:40:31Z","timestamp":1742283631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783623005627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1538783623005627"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.06.038","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumab","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.06.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}